TB-500 is a synthetic fragment associated with thymosin beta-4 and promoted online for wound and injury recovery. It is not FDA-approved, and FDA reports no identified human exposure data for drug products containing the specific fragment.
TB-500 at a glance
| Scientific description | Thymosin beta-4 fragment (LKKTETQ) |
|---|---|
| U.S. status | Not FDA-approved |
| Human evidence | No identified human drug-product exposure data for the fragment in FDA’s review |
| FDA concerns | Aggregation, peptide-related impurities, immunogenicity, and inadequate safety information |
| Reviewed | August 11, 2026 |
Is TB-500 the same as thymosin beta-4?
No. TB-500 is described as a fragment associated with thymosin beta-4. Research involving full-length thymosin beta-4 should not automatically be attributed to the fragment. Molecular identity and formulation matter.
Why is it discussed for recovery?
Online rationales often draw from biological functions associated with thymosin beta-4 or from preclinical models. That chain of inference does not demonstrate that TB-500 products improve human tendon, ligament, muscle, wound, or joint outcomes.
What has FDA said?
FDA identifies TB-500 as thymosin beta-4 fragment LKKTETQ and reports no identified human exposure data for drug products containing it. The agency also notes risks related to aggregation, peptide impurities, and immune responses. Its 2026 advisory review of compounding nominations was not product approval.
Product-quality uncertainty
Online labeling cannot establish identity, purity, sterility, concentration, or storage integrity. The absence of standardized approved labeling also makes adverse-event interpretation and product comparison difficult.
What people report online
Community-reported—not proof: users discuss wound healing, flexibility, pain, athletic recovery, no response, and reactions. These accounts often involve BPC-157, rehabilitation, altered training, or rest, preventing reliable attribution.
Frequently asked questions
Is TB-500 FDA-approved?
No. There is no FDA-approved TB-500 medicine, and research-market or compounded products are not approved treatments.
Primary sources
Educational information only; no dosing, injection, or treatment instructions.
Leave a Reply